Kite Pharma's Series A - II Round

Kite Pharma raised a round of funding on May 15, 2013.

Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to r…

Articles about Kite Pharma's Series A - II Round: